GlassScriptPhysician profile
Ashley Hardy
NPI 1528224300
$15,971.01
in general payments reported to CMS, 2019-2025
17 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $358 · 2021: $6,979 · 2022: $219 · 2023: $8,054 · 2024: $210 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,000 · Travel and Lodging: $1,766 · Food and Beverage: $648.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,000.00 |
| Travel and Lodging | $1,766.33 |
| Food and Beverage | $648.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $15,146.50 | 2021-2024 | Davinci Xi, Da Vinci Surgical System |
| Baxter Healthcare | $307.16 | 2023-2025 | Perclot, Seprafilm |
| Conmed Corporation | $143.36 | 2023-2025 | Airseal |
| Astrazeneca Pharmaceuticals LP | $124.99 | 2019 | |
| Janssen Biotech, INC. | $25.80 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $23.83 | 2019 | |
| Genzyme Corporation | $23.66 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.76 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $20.60 | 2019 | |
| Rigel Pharmaceuticals, INC. | $20.31 | 2019 | |
| Abbvie INC. | $19.80 | 2019 | |
| Novartis Pharmaceuticals Corporation | $18.72 | 2019 | |
| Kyowa Kirin, INC. | $16.29 | 2019 | |
| Inspire Medical Systems, INC. | $15.53 | 2024 | Inspire |
| Verastem, INC. | $15.47 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $14.50 | 2019 | |
| Amgen INC. | $13.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Hardy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.